tm logo
HAEMOCER
Live/Registered
PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED

on 09 Jun 2022

Last Applicant/ Owned by

Ludwig-Thoma-Str. 36c

Bayreuth

DE

95447

Serial Number

79159184 filed on 23rd Sep 2014

Registration Number

4771003 registered on 14th Jul 2015

in the Principal Register

Correspondent Address

Jeanne Hamburg

Jeanne Hamburg Norris McLaughlin, P.A.

New York, NY 10036-6524

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

HAEMOCER

[ Products for medical purposes, namely, dispensers and applicators for dispensing and applying haemostatic substances in powder form to stop bleeding during surgery ] Styptic preparations, namely, haemostatic substances in powder form to stop bleeding during surgery

Classification Information


Class [010]
Medical Instrument Products


[ Products for medical purposes, namely, dispensers and applicators for dispensing and applying haemostatic substances in powder form to stop bleeding during surgery ]


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Styptic preparations, namely, haemostatic substances in powder form to stop bleeding during surgery


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79159184

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 122098-34

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
10th Oct 2024INTERNATIONAL REGISTRATION RENEWED
05th Aug 2024TEAS SECTION 71 RECEIVED
14th Jul 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
23rd Apr 2023PARTIAL INVALIDATION PROCESSED BY THE IB
24th Mar 2023PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
24th Mar 2023INVALIDATION PROCESSED
09th Feb 2023PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
23rd Oct 2022NEW REPRESENTATIVE AT IB RECEIVED
10th Sep 2022NEW REPRESENTATIVE AT IB RECEIVED
09th Jun 2022NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED